InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: jomama9231 post# 261303

Friday, 04/03/2020 1:10:07 PM

Friday, April 03, 2020 1:10:07 PM

Post# of 424188
j-

Thx.

Doc 331

Kurabayashi was considered by the United States Patent and Trademark Office during the prosecution of the Asserted Patents


Doc 381

the Patent Office’s examiner did not consider Kurabayashi. (Id. at 246-47.)

However it is confusing (Doc 373):

The examiner did not cite Kurabayashi, which showed that EPA reduced Apo B.

More DD is required. (First of all: find the "Id. at 246-47.").

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News